These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9236549)

  • 1. Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study.
    Goldsmith SK; Shapiro RM; Joyce JN
    Arch Gen Psychiatry; 1997 Jul; 54(7):649-58. PubMed ID: 9236549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2 receptors are organized in bands in normal human temporal cortex.
    Goldsmith SK; Joyce JN
    Neuroscience; 1996 Sep; 74(2):435-51. PubMed ID: 8865195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptor expression in hippocampus and parahippocampal cortex of rat, cat, and human in relation to tyrosine hydroxylase-immunoreactive fibers.
    Goldsmith SK; Joyce JN
    Hippocampus; 1994 Jun; 4(3):354-73. PubMed ID: 7842057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease.
    Joyce JN; Myers AJ; Gurevich E
    Brain Res; 1998 Feb; 784(1-2):7-17. PubMed ID: 9518532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugs. [123I]epidepride single photon emission tomography (SPET) study.
    Bigliani V; Mulligan RS; Acton PD; Visvikis D; Ell PJ; Stephenson C; Kerwin RW; Pilowsky LS
    Br J Psychiatry; 1999 Sep; 175():231-8. PubMed ID: 10645324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride.
    Hall H; Farde L; Halldin C; Hurd YL; Pauli S; Sedvall G
    Synapse; 1996 Jun; 23(2):115-23. PubMed ID: 8723716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
    Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
    Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease.
    Joyce JN; Kaeger C; Ryoo H; Goldsmith S
    Neurosci Lett; 1993 May; 154(1-2):171-4. PubMed ID: 8361636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride.
    Kessler RM; Whetsell WO; Ansari MS; Votaw JR; de Paulis T; Clanton JA; Schmidt DE; Mason NS; Manning RG
    Brain Res; 1993 Apr; 609(1-2):237-43. PubMed ID: 8099521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.
    Tuppurainen H; Kuikka JT; Viinamäki H; Husso M; Tiihonen J
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):529-37. PubMed ID: 19496999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
    Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D
    Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limbic circuits and monoamine receptors: dissecting the effects of antipsychotics from disease processes.
    Joyce JN; Goldsmith SG; Gurevich EV
    J Psychiatr Res; 1997; 31(2):197-217. PubMed ID: 9278186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain.
    Joyce JN; Janowsky A; Neve KA
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1253-63. PubMed ID: 1828505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
    Gurevich EV; Bordelon Y; Shapiro RM; Arnold SE; Gur RE; Joyce JN
    Arch Gen Psychiatry; 1997 Mar; 54(3):225-32. PubMed ID: 9075463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.
    Piggott MA; Ballard CG; Rowan E; Holmes C; McKeith IG; Jaros E; Perry RH; Perry EK
    Synapse; 2007 Nov; 61(11):903-11. PubMed ID: 17663455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study.
    Lahti RA; Roberts RC; Cochrane EV; Primus RJ; Gallager DW; Conley RR; Tamminga CA
    Mol Psychiatry; 1998 Nov; 3(6):528-33. PubMed ID: 9857979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex.
    Lidow MS; Goldman-Rakic PS
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4353-6. PubMed ID: 8183912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.
    Werhahn KJ; Landvogt C; Klimpe S; Buchholz HG; Yakushev I; Siessmeier T; Müller-Forell W; Piel M; Rösch F; Glaser M; Schreckenberger M; Bartenstein P
    Epilepsia; 2006 Aug; 47(8):1392-6. PubMed ID: 16922886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.
    Vernaleken I; Janouschek H; Raptis M; Hellmann S; Veselinovic T; Bröcheler A; Boy C; Cumming P; Hiemke C; Rösch F; Schäfer WM; Gründer G
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):951-60. PubMed ID: 20392299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.